Literature DB >> 1600941

ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity.

E C Park1, J W Szostak.   

Abstract

Two yeast genes, ARD1 and NAT1, are required for the expression of an N-terminal protein acetyltransferase. This activity is required for full repression of the silent mating type locus HML, for sporulation, and for entry into G0. While the NAT1 gene product is thought to be the catalytic subunit of the enzyme, the role of the ARD1 protein has remained unclear. We have used epitope tagged derivatives of ARD1 and NAT1 to provide biochemical evidence for the formation of an ARD1-NAT1 complex, and to show that both proteins are required for the N-terminal acetyltransferase activity. We also present evidence for the formation of ARD1-ARD1 homodimers. Deletion analysis suggests that the C-terminal region of ARD1 may be involved in the formation of both ARD1-ARD1 and ARD1-NAT1 complexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600941      PMCID: PMC556675          DOI: 10.1002/j.1460-2075.1992.tb05267.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  16 in total

1.  The yeast regulatory gene PHO2 encodes a homeo box.

Authors:  T R Bürglin
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

2.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

3.  Purification and characterization of an N alpha-acetyltransferase from Saccharomyces cerevisiae.

Authors:  F J Lee; L W Lin; J A Smith
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

4.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  A GAL10-CYC1 hybrid yeast promoter identifies the GAL4 regulatory region as an upstream site.

Authors:  L Guarente; R R Yocum; P Gifford
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.

Authors:  J Field; J Nikawa; D Broek; B MacDonald; L Rodgers; I A Wilson; R A Lerner; M Wigler
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

7.  A strategy for the generation of conditional mutations by protein destabilization.

Authors:  E C Park; D Finley; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

8.  N alpha-acetyltransferase deficiency alters protein synthesis in Saccharomyces cerevisiae.

Authors:  F J Lee; L W Lin; J A Smith
Journal:  FEBS Lett       Date:  1989-10-09       Impact factor: 4.124

9.  N alpha acetylation is required for normal growth and mating of Saccharomyces cerevisiae.

Authors:  F J Lee; L W Lin; J A Smith
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

10.  Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast.

Authors:  J R Mullen; P S Kayne; R P Moerschell; S Tsunasawa; M Gribskov; M Colavito-Shepanski; M Grunstein; F Sherman; R Sternglanz
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  70 in total

1.  Two classes of sir3 mutants enhance the sir1 mutant mating defect and abolish telomeric silencing in Saccharomyces cerevisiae.

Authors:  E M Stone; C Reifsnyder; M McVey; B Gazo; L Pillus
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Importance of the Sir3 N terminus and its acetylation for yeast transcriptional silencing.

Authors:  Xiaorong Wang; Jessica J Connelly; Chia-Lin Wang; Rolf Sternglanz
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

3.  Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog.

Authors:  Glen Liszczak; Ronen Marmorstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

4.  A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.

Authors:  Petra Van Damme; Svein I Støve; Nina Glomnes; Kris Gevaert; Thomas Arnesen
Journal:  Mol Cell Proteomics       Date:  2014-01-09       Impact factor: 5.911

Review 5.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

6.  The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides.

Authors:  Matthias Gautschi; Sören Just; Andrej Mun; Suzanne Ross; Peter Rücknagel; Yves Dubaquié; Ann Ehrenhofer-Murray; Sabine Rospert
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

Authors:  John A Pezza; Sara X Langseth; Rochele Raupp Yamamoto; Stephen M Doris; Samuel P Ulin; Arthur R Salomon; Tricia R Serio
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

8.  Expression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilum.

Authors:  Sang Hee Han; Jun Yong Ha; Kyoung Hoon Kim; Sung Jin Oh; Do Jin Kim; Ji Yong Kang; Hye Jin Yoon; Se-Hee Kim; Ji Hae Seo; Kyu-Won Kim; Se Won Suh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

9.  TEL2, an essential gene required for telomere length regulation and telomere position effect in Saccharomyces cerevisiae.

Authors:  K W Runge; V A Zakian
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.

Authors:  Dong Hoon Shin; Yang-Sook Chun; Kyoung-Hwa Lee; Hyun-Woo Shin; Jong-Wan Park
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.